New research reveals that contrary to conventional belief, primary glomerular diseases are not necessarily benign for ...
News-Medical.Net on MSN
Pediatric patients with primary glomerular diseases may experience faster kidney function decline
New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children ...
New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In ...
The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...
"Eledon takes transplant rejection therapy to Phase III on mixed results" was originally created and published by Clinical ...
Eledon shares drop as tegoprubart misses the main goal in Phase 2 kidney transplant trial, though safety signals and kidney ...
News-Medical.Net on MSN
SGLT2 inhibitors show consistent cardio-renal protection in 70,000 patients
In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...
Nephrologists must capitalize on new therapeutic agents and opportunities to carry on the momentum of the field, according to ...
In FSGS, podocytes are damaged, like a net with torn holes, allowing protein to leak into the urine, creating a harmful ...
The benefits are observed across patient subtypes and potentially offer the chance to avoid dialysis and implement a new standard of care.
Medpage Today on MSN
Novel Injection Nearly Halved Proteinuria in IgA Nephropathy
HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients ...
The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results